PharmaCyte Biotech's Diabetes Treatment: How Would It Work?

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
How much would a cure for diabetes be worth? It's incalculable, but certainly many billions of dollars. Consider the insulin market alone is over $25 billion annually and projected to reach $40 Billion by 2018. Diabetes is a worldwide epidemic with over 350 million diabetes patients globally and growing.

A lot has been made of PharmaCyte Biotech's (OTCQB: PMCB) pending Phase 2b FDA clinical trial for Pancreatic Cancer. However, the use of their Cell-in-a-Box® technology as a potential treatment for Diabetes is not well understood.

Let's clear it up.

Diabetes occurs when the Pancreas fails to produce Insulin, or when the insulin it does produce is not effectively used by the body. Insulin regulates high levels of sugar in our blood stream.

http://www.marketwired.com/press-re...ment-how-would-it-work-otcqb-pmcb-1989471.htm
 
Status
Not open for further replies.
Back
Top